台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.2
  • 漲跌
    ▼0.3
  • 漲幅
    -0.44%
  • 成交量
    77
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-德信-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

德信-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2020/07/2700.00125.1524.90-12,248-0.04%
2020/07/22129.80430.0030.00-32,204-0.14%
2020/07/16129.0000.0029.0512,0180.05%
2020/07/13630.83231.5031.5541,7930.22%
2020/07/1000.001928.7028.70-191,666-1.14%
2020/05/2600.001021.6021.60-10902-1.11%
2020/05/2200.002517.7217.90-25930-2.69%
2020/05/2000.001014.8514.85-10827-1.21%
2020/05/0600.001512.8012.65-15761-1.97%
2020/05/051012.4000.0012.40107421.35%
2020/05/0400.00612.4012.40-6724-0.83%
2020/04/3000.001011.4111.30-10711-1.40%
2020/04/2800.00611.6011.60-6703-0.85%
2020/04/2059.7400.009.7456920.72%
2020/04/1779.7200.009.7376911.01%
2020/03/3000.0058.578.57-5678-0.74%
2020/03/2700.00209.148.80-20675-2.96%
2020/03/2600.00218.118.60-21667-3.15%
2020/03/2300.0057.687.80-5657-0.76%
2020/03/1918.03107.857.85-9650-1.38%
2020/03/1800.0098.808.72-9639-1.41%
2020/03/1000.00112.7512.75-1544-0.18%
2020/03/05114.8000.0014.3514820.21%
2020/02/2600.00214.0514.05-2321-0.62%
2020/02/25212.6500.0012.8022640.76%
2019/11/0700.00110.4010.45-189-1.12%
2019/10/0300.00610.5010.50-6148-4.03%
2019/09/241610.9500.0010.90161828.75%
2019/09/161210.9400.0011.10121796.69%
2019/09/121511.26311.2511.25121776.75%
2019/09/111111.5500.0011.80111706.45%
2019/08/2169.9700.009.9261474.08%
2019/08/14710.2000.0010.2571494.70%
2019/08/131210.3000.0010.30121498.01%
2019/08/0200.00710.8110.60-7150-4.64%
2019/08/0100.00910.8510.80-9150-5.97%
2019/07/3100.004910.7710.65-49149-32.86%
2019/07/3000.003011.0610.80-30148-20.26%
2019/06/2800.0069.809.80-666-8.99%
2019/06/2600.00179.759.80-1768-24.75%
2019/06/2500.00259.759.89-2568-36.28%
2019/05/2819.7500.009.7511010.99%
2019/05/1700.00610.7010.35-6103-5.78%
2019/05/1300.001810.9310.90-18107-16.70%
2019/05/031611.6900.0011.651611214.21%
2019/05/021611.7000.0011.751611314.15%
2019/04/2900.003111.7011.95-31113-27.43%
2019/01/18213.2000.0013.1521071.86%
2019/01/15113.1000.0013.4011010.99%
2018/12/21211.1000.0011.302633.15%
2018/12/13211.5000.0011.902623.19%
2018/12/12611.1200.0011.356619.77%
2018/12/11511.1200.0011.205608.23%
2018/11/27312.3500.0012.253853.53%
2018/10/26112.15112.1512.150890.00%
2018/07/1900.00318.4519.00-3144-2.08%
2018/07/0400.00617.2016.90-6389-1.54%
2018/06/2200.002017.6117.55-20399-5.00%
2018/06/12218.0000.0018.1023970.50%
2018/06/111118.0900.0018.05113962.77%
2018/06/08217.95618.0518.45-4396-1.01%
2018/05/1500.00118.5018.50-1397-0.25%
2018/05/1000.00718.5018.60-7396-1.77%
2018/05/0900.002818.4518.45-28395-7.08%
2018/05/0200.00519.5019.60-5380-1.31%
2018/04/181920.1400.0019.90193515.41%
2018/04/17521.0000.0020.5553421.46%
2018/04/131023.601024.2023.7003020.00%
2018/04/1000.002222.8522.85-22189-11.59%
2018/03/071019.1000.0018.90101865.35%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音